Next Article in Journal
Brain Network Organization Correlates with Autistic Features in Preschoolers with Autism Spectrum Disorders and in Their Fathers: Preliminary Data from a DWI Analysis
Next Article in Special Issue
Peptide Antagonists for P-selectin Discriminate between Sulfatide-Dependent Platelet Aggregation and PSGL-1-Mediated Cell Adhesion
Previous Article in Journal
Similar Risk of Re-Revision in Patients after One- or Two-Stage Surgical Revision of Infected Total Hip Arthroplasty: An Analysis of Revisions in the Swedish Hip Arthroplasty Register 1979–2015
Review

Immunoproteomic Lessons for Human Respiratory Syncytial Virus Vaccine Design

Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Majadahonda (Madrid), Spain
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2019, 8(4), 486; https://doi.org/10.3390/jcm8040486
Received: 8 March 2019 / Revised: 1 April 2019 / Accepted: 9 April 2019 / Published: 10 April 2019
Accurate antiviral humoral and cellular immune responses require prior recognition of antigenic peptides presented by human leukocyte antigen (HLA) class I and II molecules on the surface of antigen-presenting cells. Both the helper and the cytotoxic immune responses are critical for the control and the clearance of human respiratory syncytial virus (HRSV) infection, which is a significant cause of morbidity and mortality in infected pediatric, immunocompromised and elderly populations. In this article we review the immunoproteomics studies which have defined the general antigen processing and presentation rules that determine both the immunoprevalence and the immunodominance of the cellular immune response to HRSV. Mass spectrometry and functional analyses have shown that the HLA class I and II cellular immune responses against HRSV are mainly focused on three viral proteins: fusion, matrix, and nucleoprotein. Thus, these studies have important implications for vaccine development against this virus, since a vaccine construct including these three relevant HRSV proteins could efficiently stimulate the major components of the adaptive immune system: humoral, helper, and cytotoxic effector immune responses. View Full-Text
Keywords: Antigen processing; immune response; HLA; immunoproteomics; mass spectrometry; respiratory infectious disease; T cells; vaccine Antigen processing; immune response; HLA; immunoproteomics; mass spectrometry; respiratory infectious disease; T cells; vaccine
Show Figures

Figure 1

MDPI and ACS Style

López, D.; Barriga, A.; Lorente, E.; Mir, C. Immunoproteomic Lessons for Human Respiratory Syncytial Virus Vaccine Design. J. Clin. Med. 2019, 8, 486. https://doi.org/10.3390/jcm8040486

AMA Style

López D, Barriga A, Lorente E, Mir C. Immunoproteomic Lessons for Human Respiratory Syncytial Virus Vaccine Design. Journal of Clinical Medicine. 2019; 8(4):486. https://doi.org/10.3390/jcm8040486

Chicago/Turabian Style

López, Daniel, Alejandro Barriga, Elena Lorente, and Carmen Mir. 2019. "Immunoproteomic Lessons for Human Respiratory Syncytial Virus Vaccine Design" Journal of Clinical Medicine 8, no. 4: 486. https://doi.org/10.3390/jcm8040486

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop